Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. administers 468.5 mln doses of COVID-19 vaccines- CDC

12/04/2021 | 04:16pm EST

Dec 4 (Reuters) - The United States had administered 468,516,782 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 581,107,805 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 466,348,132 vaccine doses the CDC said had gone into arms by Dec. 3 out of 580,893,145 doses delivered.

The agency said 235,297,964 people had received at least one dose, while 198,592,167 people had been fully vaccinated as of 6:00 a.m. ET on Saturday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech,, as well as Johnson & Johnson's one-shot vaccine.

About 45.3 million people have received a booster dose of either Pfizer, Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20. (Reporting by Juby Babu in Bengaluru; Editing by Daniel Wallis)


ę Reuters 2021
All news about MODERNA, INC.
12:52pMIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
10:09aEU regulator finds mRNA COVID-19 shots safe during pregnancy
RE
10:01aEuropean Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
09:16aEU regulator says mRNA COVID-19 shots do not complicate pregnancies
RE
09:13aMARKETSCREENER’S WORLD PRESS REVIEW : January 18, 2022
01/17China's Xi rejects 'Cold War mentality,' pushes cooperation
AQ
01/17Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
RE
01/17Preliminary study at israeli hospital shows fourth shot of pfizer/biontech or moderna v..
RE
01/17Moderna To Start Clinical Development Of Vaccine Targeting Omicron Variant
MT
01/17Moderna CEO says data for Omicron-specific shot likely available in March
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 520 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 774 M - -
P/E ratio 2021 7,07x
Yield 2021 -
Capitalization 75 661 M 75 661 M -
EV / Sales 2021 3,76x
EV / Sales 2022 2,60x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 186,61 $
Average target price 273,19 $
Spread / Average Target 46,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-26.53%83 008
LONZA GROUP AG-15.15%53 950
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684
CELLTRION, INC.-19.44%18 710